CDEK
← All organizations

Retina Macula Institute

Academic/Hospital
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Oct 1, 2011

Last known activity

Apr 1, 2012

Timeline

No events for the selected filters.

Drugs by trial phase (5 distinct, 3 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 2 (4 own, 0 via acquisition)

Indications

Studied for

Recent trials (7)

  • NCT01571232Lead sponsorPhase 2Apr 1, 2012
  • NCT01571232Overall official - principal investigatorPhase 2Apr 1, 2012
  • NCT01571232Reponsible party - principal investigatorPhase 2Apr 1, 2012
  • NCT01565148Overall official - principal investigatorPhase 2Feb 1, 2012
  • NCT01449682Study directorPhase 3Oct 1, 2011
  • NCT01449682Overall official - principal investigatorPhase 3Oct 1, 2011
  • NCT01449682Lead sponsorPhase 3Oct 1, 2011

Details

Last known activity
Apr 1, 2012